Skip to content

Analysis for the correlation between colonic polyps and intestinal flora and Helicobacter pylori in Tibetan population

Analysis for the correlation between colonic polyps and intestinal flora and Helicobacter pylori in Tibetan population

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900025124
Enrollment
Unknown
Registered
2019-08-12
Start date
2019-08-01
Completion date
Unknown
Last updated
2019-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intestinal polyps

Interventions

large intestinal polyps group + non-large intestinal polyps group :N/A

Sponsors

Hospital of Chengdu Office of the People's Government of Tibet Autonomous Region
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria for the experimental group: (1) Tibetans aged 18-80 years; (2) Voluntary participation in this study; (3) Tibetan patients with large intestinal polyps (colon polyps, rectal polyps) confirmed by enteroscopy. Inclusion criteria for the control group were as follows: (1) Tibetans aged 18-80 years; (2) Voluntary participation in this study; (3) No colon polyp (colon polyp, rectal polyp) was found by enteroscopy in volunteers.

Exclusion criteria

Exclusion criteria: Exclusion criteria of experimental group: (1) Intestinal infections and inflammatory diseases, or uncontrolled infections or sepsis; (2) Patients with polyposis pigmentosa syndrome and familial polyposis; (3) Patients with malignant tumors or cachexia, or with a history of radiotherapy or chemotherapy; (4) Use of antibiotics, steroids and other hormones and probiotics in the past two weeks; (5) Pregnant or lactating women; (6) Patients with major organ failure; (7) Complicated with major diseases such as heart, lung and immune system; (8) Recent Helicobacter pylori eradication therapy; (9) Past history of gastrointestinal surgery; (10) Those who have been in the Mainland for more than two weeks and whose dietary habits have changed considerably with their original habits; (11) Incomplete clinical data. Exclusion criteria of control group: (1) There are obvious symptoms of physical discomfort; (2) There are intestinal infections and inflammatory diseases, or uncontrolled infections or sepsis; (3) Patients with malignant tumors or cachexia, or with a history of radiotherapy or chemotherapy; (4) Use of antibiotics, steroids and other hormones and probiotics in the past two weeks; (5) Pregnant or lactating women; (6) People with major organ failure; (7) Complicated with major diseases such as heart, lung and immune system; (8) Recent Helicobacter pylori eradication therapy; (9) Past history of gastrointestinal surgery; (10) Those who have been in the Mainland for more than two weeks and whose dietary habits have changed considerably with their original habits; (11) Incomplete clinical data.

Design outcomes

Primary

MeasureTime frame
Stool flora;

Countries

China

Contacts

Public ContactLiu Chao

Hospital of Chengdu Office of the People's Government of Tibet Autonomous Region

Liuchao-delta@126.com+86 18602835753

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026